Publications

Found 344 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Santisteban MM, Ahn SJi, Lane D, Faraco G, Garcia-Bonilla L, Racchumi G, Poon C, Schaeffer S, Segarra SG, Körbelin J et al..  2020.  Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension.. Hypertension. :HYPERTENSIONAHA12015581.
Martínez-Rivera A, Hao J, Tropea TF, Giordano TP, Kosovsky M, Rice RC, Lee A, Huganir RL, Striessnig J, Addy NA et al..  2017.  Enhancing VTA Cav1.3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens.. Mol Psychiatry. 22(12):1735-1745.
Anwar Z, Regan SB, Linden J.  2019.  Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples.. J Vis Exp. (152)
Goldman SL, Hassan C, Khunte M, Soldatenko A, Jong Y, Afshinnekoo E, Mason CE.  2019.  Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity.. Front Genet. 10:133.
Rubinelli L, Garcia-Bonilla L, Sasset L, Cantalupo A, Goya B, Ip JE, Anrather J, Iadecola C, Faraco G, Di Lorenzo A.  2023.  Essential Role of Endothelial Sphingolipid Biosynthesis in Cerebrovascular Homeostasis.. Circ Res. 133(10):880-882.
Almey A, Milner TA, Brake WG.  2016.  Estrogen receptor α and G-protein coupled estrogen receptor 1 are localized to GABAergic neurons in the dorsal striatum.. Neurosci Lett. 622:118-23.
Almey A, Milner TA, Brake WG.  2015.  Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females.. Horm Behav. 74:125-38.
Almey A, Milner TA, Brake WG.  2022.  Estrogen receptors observed at extranuclear neuronal sites and in glia in the nucleus accumbens core and shell of the female rat: Evidence for localization to catecholaminergic and GABAergic neurons.. J Comp Neurol.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Zook JM, Catoe D, McDaniel J, Vang L, Spies N, Sidow A, Weng Z, Liu Y, Mason CE, Alexander N et al..  2016.  Extensive sequencing of seven human genomes to characterize benchmark reference materials.. Sci Data. 3:160025.
Baradaran H, Ng CR, Gupta A, Noor NM, Al-Dasuqi KW, Mtui EE, Rijal OM, Giannopoulos A, Nicolaides A, Laird JR et al..  2017.  Extracranial internal carotid artery calcium volume measurement using computer tomography.. Int Angiol. 36(5):445-461.
G
Gupta A, Baradaran H, Al-Dasuqi K, Knight-Greenfield A, Giambrone AE, Delgado D, Wright D, Teng Z, Min JK, Navi BB et al..  2016.  Gadolinium Enhancement in Intracranial Atherosclerotic Plaque and Ischemic Stroke: A Systematic Review and Meta-Analysis.. J Am Heart Assoc. 5(8)
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.